Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Katherine Peters, MD, PhD
Duke Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama- Birmingham
Birmingham, Alabama, United States
- University of California San Francisco
San Francisco, California, United States
- University of Kentucky
Lexington, Kentucky, United States
- St. Luke'S Hospital
Kansas City, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Duke Cancer Institute
Durham, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Sept 2018
- Primary completion
- 17 Aug 2023
- Completion
- 31 Dec 2024
- Last update posted
- 8 Jun 2025
- Registered enrollment
- 177
- Registry id
- NCT02655601
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.